THE E-3620 DIARIES

Molnupiravir is simpler to administer within an outpatient location, needs only temporary oral administration, and thus has larger compliance. The advantage of a drugs including molnupiravir is that, in contrast to other EUA approved treatment plans for COVID-19, produced on a greater scale, it does not need cold storage and will be administered ou